7.6 C
Glasgow
Saturday, December 13, 2025
spot_img

More News

Potent and selective antitumour activity in acute myeloid leukaemia study

Jim Cornall -
Orum Therapeutics, a public biotechnology company working on degrader-antibody conjugates (DACs), has presented preclinical data for ORM-1153 at the...

Positive results from male and female infertility monoclonal antibody trial

Jim Cornall -
French infertility treatment biotech company Igyxos Biotherapeutics has announced the successful completion of its phase 1 clinical trial evaluation...

Positive results from ALS study

Jim Cornall -
AL-S Pharma has presented phase 2 clinical study results on AP-101 to treat amyotrophic lateral sclerosis (ALS) at the...

EspeRare receives Gates Foundation grant to advance preeclampsia novel therapy

Jim Cornall -
EspeRare, a Geneva-based nonprofit biotech, has been awarded a Grand Challenges grant from the Gates Foundation to strengthen its...

CRO Avetra launched

Jim Cornall -
Contract research organization (CRO) Avetra has officially launched with the aim of introducing a site-centric operating model to realign...

7,920 acre next-gen industry facility IBTEC launched in Malaysia

Jim Cornall -
JLand Group (JLG), the real estate and infrastructure arm of Johor Corporation (JCorp) in Malaysia, has launched Ibrahim Technopolis...

Oncoinvent publishes phase 1 ovarian cancer results

Jim Cornall -
Oncoinvent, a clinical stage, radiopharmaceutical company developing treatments for solid cancers, has announced the publication of 12-month data from...

Lower doses of immunotherapy for skin cancer give better results

Jim Cornall -
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumours,...

New RNA class discovered

Jim Cornall -
Inside cells, RNAs and proteins form tiny, liquid-like droplets called biomolecular condensates. These droplets are essential for organising cellular...

Base to Base biotech podcast 38: Obesity, life sciences in the Netherlands, and killing cancer cells

Jim Cornall -
This week, we have conversations with Sjanna Bosma, international relations officer at Health Holland; Mark Bagnall, CEO of Phenomix;...

IonQ and CCRM to collaborate on advanced therapeutics

Jim Cornall -
Quantum company IonQ has announced an investment partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate...

Researchers discover latent antimicrobial resistance across the world

Jim Cornall -
A group of researchers has analysed 1,240 wastewater samples from 351 cities in 111 different countries and found that...

Early detection of cancer in Taiwan

Jim Cornall -
Precision medicine is entering a new era, driven by breakthroughs in genetic technology and artificial intelligence (AI). Multi-cancer early...

Protego Biopharma raises $130m for AL amyloidosis programme

Jim Cornall -
Protego Biopharma, Inc., a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule therapeutics that reprogramme protein folding to...

Belgian company looks to Uzbekistan to expand biotech footprint

Jim Cornall -
Deputy Minister of Investment, Industry and Trade of the Republic of Uzbekistan, Akram Aliyev, held a meeting with the...

New era in precision protein design?

Jim Cornall -
Galux, a South Korean biotech pioneering AI-driven protein therapeutics design, has announced new experimental findings demonstrating that its AI...

Results ‘approach Holy Grail’ of cancer research

Jim Cornall -
Lunai Bioworks has secured its first letter of intent (LOI) to license its next-generation immune cell therapy, which achieved...

Positive phase 1 Alzheimer’s disease data

Jim Cornall -
Swiss company Vandria SA has announced topline results from its first-in-human clinical trial of its lead central nervous system...

Patronus Biotech receives grant to evaluate novel malaria vaccine

Jim Cornall -
Singaporean company Patronus Biotech has received a grant from the Gates Foundation to accelerate the development of its novel...

Collaboration boosts cell therapy production

Jim Cornall -
NorthX Biologics, a leading CDMO and Swedish national innovation hub for advanced biologics, and Mendus, a Swedish-Dutch immuno-oncology company...

RSV vaccines could offer protection against asthma

Jim Cornall -
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered evidence that early-infancy infection with...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media